-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

632A.O1.6 632. Chronic Myeloid Leukemia: Therapy: Clinical Trials, Observations, and Molecular Monitoring

Chronic Myeloid Leukemia: Therapy Program: Oral and Poster Abstracts
Type: Oral
Saturday, December 5, 2015: 4:00 PM-5:30 PM
Valencia BC (W415BC), Level 4 (Orange County Convention Center)
Moderators:
Neil P. Shah, MD, PhD, University of California - San Francisco and Yosuke Minami, MD, PhD, Kobe University Hospital

Disclosures:
No relevant conflicts of interest to declare.
4:00 PM

Philippe Rousselot, MD, PhD1,2,3*, Hyacinthe Johnson-Ansah, MD3,4*, Françoise Huguet, MD3,5,6*, Laurence Legros, MD3,7*, Martine Escoffre-Barbe3,8*, Martine Gardembas, MD3*, Pascale Cony-Makhoul, MD3,9*, Valérie Coiteux, MD3,10*, Laurent Sutton, MD11*, Wajed Abarah, MD3,12*, Camille Pouaty, MD3,13*, Jean Michel Pignon, MD3,14*, Bachra Choufi, MD3,15*, Sorin Visanica, MD3,16,17*, Bénédicte Deau, MD3,18*, Stephane Bouchet, MD PhD19*, Francois Guilhot, MD3,20, Francois-Xavier Mahon, MD, PhD, Professor3,21,22*, Laure Morisset23*, Jean-Michel Cayuela3,24* and Benjamin Maneglier, MD25*

1Hematology Department, Hôpital André Mignot, Versailles, France
2University of Versailles St-Quentin-en-Yvelines, Versailles, France
3Fi-LMC group, Pessac, France
4Hematology department, CHU Caen, Caen, France
5CHU Toulouse, Toulouse, France
6Hematology department, Institut universitaire du cancer de Toulouse, Toulouse, France
7Hematology department, Hopital Archet 1, CHU Nice, Nice, France
8Hematology department, Hôpital Pontchaillou, CHU Rennes, Rennes, France
9Centre Hospitalier Annecy Genevois, Pringy, France
10Hematology department, Hôpital Claude Huriez, Lille, France
11Hematology Department, Argenteuil Hospital, Argenteuil, France
12Hospital, Meaux, France
13Centre hospitalier de Dieppe, Dieppe, France
14Haematology, CH Dunkerque, Dunkerque, France
15Hôpital de Boulogne-sur-Mer, Boulogne-sur-Mer, France
16Hôpital Bons Secours, Metz, France
17CH de METZ, Metz, France
18Hôpital Cochin AP-HP, Paris, France
19Pharmacology, Universite Victor Segalen Bordeaux 2, Bordeaux, France
20Clinical Investigation Center, INSERM CIC 1402, CHU de Poitiers, Poitiers, France
21Hematology department, Institut Bergonié, Bordeaux, France
22Inserm U1035, Université Bordeaux Segalen, Bordeaux, France
23Clinical research center, Hôpital Mignot, Le Chesnay, France
24Hematology, Hôpital Saint-Louis, Paris, France
25Pharmacology, Hôpital Mignot, Le Chesnay, France

4:15 PM

Lydia ROY, MD1,2*, Jean-Claude Chomel, PharmD PhD3*, Joelle Guilhot, PhD4, Agnes Guerci-Bresler, MD5*, Martine Escoffre-Barbe6*, Stéphane Giraudier, MD, PhD7*, Aude Charbonnier8*, Viviane Dubruille, MD9*, Françoise Huguet10*, Hyacinthe Johnson-Ansah, MD11*, Pascal Lenain, MD12*, Shanti Amé, MD13*, Gabriel Etienne, MD, PhD14*, Franck E. Nicolini15, Delphine Rea, MD, PhD16*, Pascale Cony-Makhoul, M.D.17*, Stephane Courby, MD18*, Jean-Christophe Ianotto, MD19*, Laurence Legros, MD20*, Martine Delain, MD21*, Valérie Coiteux, MD22*, Eric Hermet, MD23*, Martine Gardembas, MD24*, Mathieu Molimard, MD, PhD25*, Jean-Michel Cayuela26*, Marie Thibaud, CRA27*, Sophie Duranton, PharmD28*, Francois-Xavier Mahon, MD, PhD29*, Philippe Rousselot, MD, PhD, Professor30* and Francois Guilhot, MD4

1INSERM CIC 1402, CHU Poitiers, Poitiers, France
2Hematology department, Hôpital Henri Mondor, APHP, Créteil, France
3Molecular biology department, CHU Poitiers, Poitiers, France
4Clinical Investigation Center, INSERM CIC 1402, CHU de Poitiers, Poitiers, France
5Hematology department, Hôpital d'Adultes du Brabois, CHU Nancy, Nancy, France
6Hematology department, Hôpital Pontchaillou, CHU Rennes, Rennes, France
7Hematology Laboratory, Hôpital Henri Mondor, APHP, Créteil, France
8Hematology department, Institut Paoli Calmettes, Marseille, France
9Department of Hematology, Nantes University Hospital, Nantes, France
10Hematology, Institut Universitaire du Cancer, Toulouse, France
11Hematology department, CHU Caen, Caen, France
12Hematology department, Centre Henri Becquerel, Rouen, France
13Hematology department, Hôpital Civil , CHU Strasbourg, Strasbourg, France
14Hematology department, Institut Bergonié, Bordeaux, France
15Hématologie, Centre Hospitalier Lyon Sud, Pierre Benite, & INSERM, Lyon, France
16Adult hematology department, Hôpital Saint-Louis, APHP, Paris, France
17Hematology department, Centre Hospitalier Annecy-Genevois, Site Annecy, Metz-Tessy, France
18Hematology department, CHU Grenoble, Grenoble, France
19Hematology department, institute of oncology and Hematology, Morvan Hospital, CHRU Brest, Brest, France
20Hematology department, Hopital Archet 1, CHU Nice, Nice, France
21Hematology department, Hôpital Bretonneau, CHU Tours, Tours, France
22Hematology department, Hôpital Claude Huriez, CHRU Lille, Lille, France
23Hematology department, CHU d’Estaing, Clermont-Ferrand, France
24Hematology department, University Hospital, Angers, France
25Pharmacology department, INSERM U657, CHU Bordeaux, Bordeaux, France
26Hematology, Hôpital Saint-Louis, Paris, France
27Clinical Investigation Center, INSERM CIC 1402, CHU Poitiers, Poitiers, France
28Pharmacovigilance, CHU Poitiers, Poitiers, France
29Hematology laboratory, Hôpital Pellegrin, CHU Bordeaux, Bordeaux, France
30Hematology department, Hôpital André Mignot, Versailles, France

4:30 PM

Georg-Nikolaus Franke, MD1*, Jacqueline Maier, PhD1*, Kathrin Wildenberger1*, Michael Cross, PhD1*, Oliver Frank, PhD2*, Frank Giles, MD MB3*, Andreas Hochhaus, MD4, Christian T. Dietz, PhD5*, Martin C. Müller5*, Dietger Niederwieser, MD1 and Thoralf Lange, MD1,6*

1Abteilung für Hämatologie/Onkologie, Universität Leipzig, Leipzig, Germany
2Novartis Pharma GmbH, Nuernberg, Germany
3NMDTI, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
4Universitätsklinikum Jena, Jena, Germany
5III. Medizinische Klinik, Medizinische Fakultät Mannheim der Ruprechts-Karl-Universität Heidelberg, Mannheim, Germany
6Asklepios Klinikum Weißenfels, Weißenfels, Germany

4:45 PM

Alice Huang*, Jennifer Salcius, MBA, MS*, Connie Wong, PhD*, Stephane Wong and Sha-Sha Wang, PhD*

Novartis Companion Diagnostics, Cambridge, MA

5:00 PM

Marc G Berger, MD, PhD, Professor1,2,3, Bruno Pereira, PhD4*, Charlotte Oris, PhD1*, Sandrine Saugues1*, Pascale Cony-Makhoul, MD3,5*, Martine Gardembas, MD3,6*, Laurence Legros, MD3,7*, Martine Escoffre-Barbe3,8*, Franck E. Nicolini, MD, PhD3,9, Philippe Rousselot, MD, PhD, Professor3,10*, Delphine Rea, MD, PhD3,11*, Joelle Guilhot, PhD3,12, Marie Zénut, MD, PhD13*, Agnès Guerci, MD, PhD3,14*, Stephane Giraudier, MD, PhD, Professor3,15* and Francois-Xavier Mahon, MD, PhD, Professor3,16*

1Hematology (Biology), CHU Clermont-Ferrand, Clermont-Ferrand, France
2CHU Clermont-Ferrand, Haematology department, Clermont-Ferrand, France
3Fi-LMC group, Pessac, France
4Direction de la Recherche Clinique et de l'Innovation, CHU Clermont-Ferrand, Clermont-Ferrand, France
5CHANGE, PRINGY CEDEX, France
6Hematology department, University Hospital, Angers, France
7Hematology department, Hopital Archet 1, CHU Nice, Nice, France
8Hematology, Hôpital Pontchaillou, Rennes, France
9Centre Hospitalier Lyon Sud, Pierre-Bénite, France
10University of Versailles St-Quentin-en-Yvelines, Versailles, France
11Adult hematology department, Hôpital Saint-Louis, APHP, Paris, France
12Inserm CIC 1402, University Hospital, Poitiers, France
13Centre Régional de Pharmacovigilance, CHU Clermont-Ferrand, Clermont-Ferrand, France
14Hématologie Clinique, CHU Nancy-Brabois, Vandoeuvre, France
15Hôpital Henri-Mondor, Créteil, France
16Laboratory of Hematology, Hôpital haut Lévêque, Pessac, France

5:15 PM

Oliver G. Ottmann, MD1*, Giuliana Alimena2, Daniel J. DeAngelo, MD, PhD3, Yeow-Tee Goh, MBBS, MMed4, Michael C. Heinrich, MD5, Andreas Hochhaus, MD6, Timothy P. Hughes, MD, MBBS, FRACP, FRCPA7, Francois-Xavier Mahon, MD, PhD, Professor8*, Michael J. Mauro, MD9, Hironobu Minami, MD, D.Med.Sci.10*, Marie Huong Nguyen, MD11*, Delphine Rea12*, Juan Luis Steegmann, MD13, Arkendu Chatterjee14*, Varsha Iyer14*, Noelia Martinez14*, Gary J. Vanasse, MD14 and Kim Dong-Wook, MD, PhD15*

1Department of Haematology, Cardiff University, Cardiff, United Kingdom
2Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
4Department of Clinical Research, Singapore General Hospital, Singapore, Singapore
5Oregon Health & Science University, Portland, OR
6Abteilung Hämatologie/Onkologie, Universitätsklinikum Jena, Jena, Germany
7SA Pathology and South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia
8Laboratoire Hématopoïèse Leucémique et Cible Thérapeutique, Inserm U1035, Université Victor Ségalen, Bordeaux, France
9Memorial Sloan Kettering Cancer Center, New York, NY
10Kobe University School of Medicine, Kobe, Japan
11Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
12Service des Maladies du Sang et EA3518, Hôpital Saint-Louis, Paris, France
13Hematology Dpt. IIS-IP, Hospital Universitario de la Princesa, Madrid, Spain
14Novartis Institutes for BioMedical Research, Inc., Cambridge, MA
15Seoul St. Mary's Hospital, Catholic University of Korea, Seoul, South Korea

*signifies non-member of ASH